JC02-88 Trial

A revolutionary approach – jCell Therapy

jCell is a first-in-class investigational treatment in late-stage clinical development for retinitis pigmentosa (RP), and other inherited retinal and blinding diseases.

View ouR Platform

Proprietary platform for multiple ophthalmic indications

jCyte is pursuing multiple drug development programs for a range of degenerative retinal disorders and optic nerve conditions, focusing on preserving and restoring vision in patients.